Recombinant human growth hormone (191 aa). The upstream GH/IGF-1 axis activator. FDA-approved since 1985. Drives body composition, bone density, wound healing and metabolic function via JAK2/STAT5b. [...]
Long-acting GHRH analogue. Stimulates pituitary GH release in pulses. Combined with Ipamorelin for synergistic GH secretion. DAC (Drug Affinity Complex) extends half-life from 30 min to 6–8 days. [...]